Abbott stock rose Wednesday after the health care giant narrowly beat Wall Street's third-quarter expectations and raised the midpoint of its earnings outlook. Please watch the video at Investors ...

Sales growth in the medical devices segment drove Abbott Laboratories’ expectations-beating revenue in the past financial quarter as the company faces lower demand for COVID-19 tests ...

The company's medical devices unit generated $4.75 billion in sales for the third quarter, above analysts' average estimate of $4.68 billion, according to data compiled by LSEG. Overall ...

With a market cap of $202.2 billion, North Chicago, Illinois-based Abbott Laboratories (ABT) is a global healthcare company.

https://www.tipranks.com/news/the-fly/abbott-reports-q3-worldwide-medical-devices-sales-up-11-7-on-reported-basis Worldwide Medical Devices sales increased 11.7% on a ...

CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals, leading to raised full-year EPS guidance. Despite ongoing NEC baby formula lawsuits ...

The Sydney Marathon is now an Abbott World Marathon Major, joining the ranks of elite marathons in Boston, London, New York, ...

Abbott (NYSE:ABT) today announced data demonstrating the long-term effectiveness of its Esprit BTK drug-eluting stent.

With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...

Medical technology firms such as Becton, Boston Scientific and Abbott Laboratories have been benefiting from robust demand ...

NBC's new 'Office'-style mock-documentary workplace comedy introduces the overworked, underappreciated staff of a regional ...